176 related articles for article (PubMed ID: 1386353)
21. Human T cell activation induced by a monoclonal mouse IgG3 anti-CD3 antibody (RIV9) requires binding of the Fc part of the antibody to the monocytic 72-kDa high-affinity Fc receptor (FcRI).
Ceuppens JL; Van Vaeck F
Cell Immunol; 1989 Jan; 118(1):136-46. PubMed ID: 2521302
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation.
Portoles P; Rojo J; Golby A; Bonneville M; Gromkowski S; Greenbaum L; Janeway CA; Murphy DB; Bottomly K
J Immunol; 1989 Jun; 142(12):4169-75. PubMed ID: 2470817
[TBL] [Abstract][Full Text] [Related]
23. Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody.
Vázquez AM; Pérez A; Hernández AM; Macías A; Alfonso M; Bombino G; Pérez R
Hybridoma; 1998 Dec; 17(6):527-34. PubMed ID: 9890708
[TBL] [Abstract][Full Text] [Related]
24. Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody.
Alegre ML; Collins AM; Pulito VL; Brosius RA; Olson WC; Zivin RA; Knowles R; Thistlethwaite JR; Jolliffe LK; Bluestone JA
J Immunol; 1992 Jun; 148(11):3461-8. PubMed ID: 1534096
[TBL] [Abstract][Full Text] [Related]
25. CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma.
Pohl C; Renner C; Schwonzen M; Schobert I; Liebenberg V; Jung W; Wolf J; Pfreundschuh M; Diehl V
Int J Cancer; 1993 May; 54(3):418-25. PubMed ID: 8389737
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
Li G; Hu J; Zhou G; Zhu J; Sun Q
Chin Med J (Engl); 2001 Sep; 114(9):962-6. PubMed ID: 11780392
[TBL] [Abstract][Full Text] [Related]
27. Network of idiotypic and anti-idiotypic antibodies related to the ovarian carcinoma-associated folate binding protein.
Pupa SM; Bazzini P; Menard S; Colnaghi MI
Anticancer Res; 1992; 12(5):1565-70. PubMed ID: 1332580
[TBL] [Abstract][Full Text] [Related]
28. Differential activation through the TCR-CD3 complex affects the requirement for costimulation of human T cells.
Kawaguchi M; Eckels DD
Hum Immunol; 1995 Jun; 43(2):136-48. PubMed ID: 7591873
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of rejection during OKT3 therapy: propagation and characterization of CD3 resistant allospecific cytotoxic T cells from a rejecting liver allograft.
Sutherland FR; Aboujaoude M; White MJ; Yamada J; Ghent C; Grant D; Wall W; Garcia B; Mazaheri R; Lazarovits AI
Clin Immunol Immunopathol; 1991 Jul; 60(1):40-54. PubMed ID: 1828398
[TBL] [Abstract][Full Text] [Related]
30. Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAb) with potential usefulness in bispecific mAb generation.
Jacobs N; Mazzoni A; Mezzanzanica D; Negri DR; Valota O; Colnaghi MI; Moutschen MP; Boniver J; Canevari S
Cancer Immunol Immunother; 1997 Jul; 44(5):257-64. PubMed ID: 9247560
[TBL] [Abstract][Full Text] [Related]
31. Production and characterization of monoclonal anti-CD18 anti-idiotype antibodies.
Hildreth JE; Hyman JA
Mol Immunol; 1989 Dec; 26(12):1155-67. PubMed ID: 2698997
[TBL] [Abstract][Full Text] [Related]
32. Prediction of successful allograft rejection retreatment with OKT3.
Legendre C; Kreis H; Bach JF; Chatenoud L
Transplantation; 1992 Jan; 53(1):87-90. PubMed ID: 1733090
[TBL] [Abstract][Full Text] [Related]
33. Polyclonal anti-idiotypic antibodies mimicking the small cell lung carcinoma antigen cluster-5A interact with a panel of antibodies and induce specific immune response in animals.
Zwicky C; Stahel RA; Jaksche H; Waibel R; Lehmann HP; Loibner H
Br J Cancer Suppl; 1991 Jun; 14():67-70. PubMed ID: 1645576
[TBL] [Abstract][Full Text] [Related]
34. Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44.
Rothman BL; Blue ML; Kelley KA; Wunderlich D; Mierz DV; Aune TM
J Immunol; 1991 Oct; 147(8):2493-9. PubMed ID: 1833455
[TBL] [Abstract][Full Text] [Related]
35. High idiotypic connectivity of the VH7183-encoded antibodies directed to a murine embryonic carbohydrate antigen, Lewis Y, as ascertained by syngenic anti-idiotype monoclonal antibodies.
Hirashima K; Zenita K; Takada A; Kitahara A; Ishihara G; Harada R; Ohmori K; Hirohashi S; Kyoizumi S; Akiyama M
J Immunol; 1990 Jul; 145(1):224-32. PubMed ID: 1972718
[TBL] [Abstract][Full Text] [Related]
36. Induction of an immune response through the idiotypic network with monoclonal anti-idiotype antibodies in the carcinoembryonic antigen system.
de Moraes JZ; Carneiro CR; Buchegger F; Mach JP; Lopes JD
J Cell Biochem; 1992 Nov; 50(3):324-35. PubMed ID: 1281819
[TBL] [Abstract][Full Text] [Related]
37. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3).
Demanet C; Brissinck J; Van Mechelen M; Leo O; Thielemans K
J Immunol; 1991 Aug; 147(3):1091-7. PubMed ID: 1830596
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of transmembrane signaling by cross-linking of antibodies against the beta chain of the T cell antigen receptor of JURKAT T cells.
Jeddi-Tehrani M; Chow SC; Ansotegui IJ; Jondal M; Wigzell H
Cell Immunol; 1992 Apr; 141(1):1-9. PubMed ID: 1372841
[TBL] [Abstract][Full Text] [Related]
39. Modulatory effect of aggregating the CD3 molecular complex on T cell activation.
Gur H; Wacholtz MC; Davis LS; Geppert TD; Lipsky PE
Cell Immunol; 1992 Mar; 140(1):81-96. PubMed ID: 1531456
[TBL] [Abstract][Full Text] [Related]
40. The IgE humoral response in OKT3-treated patients. Incidence and fine specificity.
Abramowicz D; Crusiaux A; Niaudet P; Kreis H; Chatenoud L; Goldman M
Transplantation; 1996 Feb; 61(4):577-81. PubMed ID: 8610384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
